Maternal age and NSAID use during the preconception period were associated with a longer time to pregnancy among women with SpA.

Discover how resolving MRI-detected inflammation improves clinical outcomes for aptients with axial spondyloarthritis.

UCB SA (OTCMKTS:UCBJY – Get Free Report)’s stock price passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $96.49 and traded as low as $93.22.

Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on data from 2 phase 3 trials: BE OPTIMAL and BE COMPLETE.

UCB, a global biopharmaceutical company, announced today that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX® (bimekizumab-bkzx) is now available. These ...

Efficacy endpoints included the proportion of patients achieving an at least 40% improvement in Assessment of SpondyloArthritis International Society (ASAS40) criteria and Axial Spondyloarthritis ...

Axial spondyloarthritis is a chronic rheumatological disease that primarily affects the sacroiliac joints and the spine, but often also involves the peripheral skeleton and other organs. The disease ...

A PHASE III study has demonstrated that bimekizumab, a novel treatment for axial spondyloarthritis (axSpA), significantly reduces pain, morning stiffness, and fatigue, offering hope for patients with ...

Objectives The Assessment of SpondyloArthritis International Society (ASAS) aimed to develop a set of quality standards (QS) to help improve the quality of healthcare provided to adult patients ...

MoonLake Immunotherapeutics (MLTX) announced that patients have been screened in three new trials across three new indications to evaluate ...

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent hidradenitis suppurativa (HS), Phase 2 LEDA trial in palmoplantar ...

Odyssey Therapeutics is a Pharmaceuticals and Healthcare company that provides immunomodulators and oncology drugs. The Company is Headquartered in San Francisco, California, The U.S. For a complete ...